MACS Matchmaker

Anti-tag capture adapters — protocol

The lino anti-tag adapter system uses oriented capture proteins (Protein A/G + Protein A/G/L, trisNTA, Strep-Tactin XT, anti-GFP VHH) that are pre-conjugated to a chosen oligonucleotide sequence and ship ready-to-use from the catalogue. Each adapter hybridizes to the Oligo|PEG chip via DDI, then the tagged ligand is loaded in a capture step. The chip is regenerable at the duplex level between different tagged ligands, and the captured ligand can additionally be eluted via its tag (e.g. imidazole for His-tag, low pH for Fc-captured IgGs) without stripping the duplex.

Before you start

  • Read Safety & Compliance and the safety data sheet for every reagent below. The SDS, not this page, governs how a reagent is handled, stored and disposed of.
  • Use the personal protective equipment and the waste route your laboratory prescribes for these reagent classes.
  • Check this protocol against the materials actually in hand: confirm the intended Seq ID, the product revision, the lot-specific certificate and the instructions supplied with it. Where those differ from this page, the documentation supplied with the material governs.

Available adapters

All catalogue adapters share the same format: 110 µL stock at 2.6 µM in PBST, enough for 10 immobilizations at the recommended 200 nM working concentration (130 µL/injection). Each is pre-conjugated to a single Seq ID (01–64) chosen at order time; Seq ID 00 is reserved for the backfilling strand — combine adapters with different Seq IDs to multiplex on a standard 8×8 Oligo|PEG chip (6×9 on request).

ridgegroovesubstrateAnalyteLigandtaggedAdapterProtein A/G, TrisNTA orStrep-Tactin XTChip strandSeq ID 01–64
The adapter carries the anti-tag capture module, so the ligand needs no chemistry of its own — it is held by its tag and released again by the matching elution condition.
AdapterTag / ligand capturedElutionWebshop
Protein A/G + Protein A/G/LHuman / mouse IgG (Fc region) for the A/G variant; A/G/L also captures kappa light chains (Fabs and scFvs with a κ chain)pH 2.0 glycine or duplex stripView in shop
TrisNTA6×His-tag (requires NiSO₄ pre-loading — not included)250 mM imidazole or 50 mM EDTAView in shop
Strep-Tactin XTStrep-tag II and Twin-Strep-tag5 mM desthiobiotin or duplex stripView in shop
Anti-GFP VHHGFP-fusion proteinsDuplex stripView in shop

General protocol (all adapters)

Each adapter follows the same three-step DDI capture workflow:

  1. Adapter-oligo hybridization. Flow the adapter-oligo conjugate (200 nM in PBST) over the Oligo|PEG chip for 5 min. The chip is now loaded with oriented capture sites.
  2. Tagged ligand capture. Flow the tagged protein at a sub-saturating concentration (typically 10–100 nM) for 3–5 min. Monitor the signal in real time and stop when the desired loading level is reached.
  3. Analyte measurement. Run the analyte concentration series at 30 µL/min (6-ch) / 60 µL/min (3–4-ch) / 100 µL/min (1-ch) for association and 200 µL/min for dissociation. Regenerate with tag-specific elution or strip the duplex for a fresh adapter load.

Protein A/G — IgG and antibody fragment capture

ParameterValue
AdapterProtein A/G-oligo (Fc capture) or Protein A/G/L-oligo (Fc + Vκ capture) — order one Seq ID per loaded ridge
Adapter stock110 µL at 2.6 µM in PBST (10 immobilizations per vial)
Working dilution200 nM in PBST, 130 µL injection
Hybridisation flow rate / contact time10 µL/min, 5 min
IgG loading concentration10–100 nM in PBST
Loading flow rate / contact time10 µL/min, 3–5 min (to desired signal, not necessarily saturation)
SCK association flow rate30 µL/min (6-ch) / 60 µL/min (3–4-ch) / 100 µL/min (1-ch)
SCK dissociation flow rate200 µL/min
Regeneration option A (tag elution)10 mM glycine pH 2.0, 30 s — releases IgG, leaves adapter on chip
Regeneration option B (duplex strip)3 M GuHCl + 125 mM NaOH, 400 µL/min, 0.5 min

TrisNTA — His-tag capture

ParameterValue
AdapterTrisNTA-oligo, one Seq ID per loaded ridge
Adapter stock110 µL at 2.6 µM in PBST (10 immobilizations per vial)
Working dilution200 nM in PBST, 130 µL injection
Hybridisation flow rate / contact time10 µL/min, 5 min
Ni²⁺ pre-loading500 µM NiSO₄ in PBST (NiSO₄ not included in the adapter vial), 10 µL/min, 2 min; wash with PBST (200 µL/min) to remove excess Ni²⁺ before loading His-tagged protein
His-tagged ligand concentration10–100 nM in PBST
Loading flow rate / contact time10 µL/min, 3–5 min
SCK association flow rate30 µL/min (6-ch) / 60 µL/min (3–4-ch) / 100 µL/min (1-ch)
SCK dissociation flow rate200 µL/min
Regeneration option A (His elution)250 mM imidazole in PBST — releases His-tagged protein
Regeneration option B (chelation)50 mM EDTA in PBST — strips Ni²⁺ and ligand; re-load Ni²⁺ to reuse
Regeneration option C (duplex strip)3 M GuHCl + 125 mM NaOH, 400 µL/min, 0.5 min

Strep-Tactin XT — Strep-tag II capture

ParameterValue
AdapterStrep-Tactin XT-oligo, one Seq ID per loaded ridge
Adapter stock110 µL at 2.6 µM in PBST (10 immobilizations per vial)
Working dilution200 nM in PBST, 130 µL injection
Hybridisation flow rate / contact time10 µL/min, 5 min
Strep-tagged ligand concentration10–50 nM in PBST
Loading flow rate / contact time10 µL/min, 3–5 min
SCK association flow rate30 µL/min (6-ch) / 60 µL/min (3–4-ch) / 100 µL/min (1-ch)
SCK dissociation flow rate200 µL/min
Regeneration (tag elution)5 mM desthiobiotin in PBST, 2 min — releases Strep-tag II ligand; Strep-Tactin XT adapter remains on chip for next capture
Regeneration (duplex strip)3 M GuHCl + 125 mM NaOH, 400 µL/min, 0.5 min

QC and acceptance

Capture is two hybridization-and-binding steps in series, and they fail for unrelated reasons. Record the response of each step separately — the pair identifies which one failed, where a single end-point measurement cannot.

  • Adapter loading. The adapter injection gives a response that persists through the wash. No response here is a loading failure: wrong or degraded adapter, a surface that was not available, or a buffer that suppresses hybridization. Nothing downstream can succeed, so stop and fix it.
  • Ligand capture. With the adapter loaded, the ligand injection gives its own persistent response. Loading that worked followed by capture that did not points at the ligand rather than the surface — tag absent, cleaved or sterically occluded, a mismatched adapter, or a pH at which that adapter does not bind its tag.
  • Capture stability. Affinity capture is reversible by construction. Watch the baseline between loading and analyte injection: a steady downward drift is ligand leaving the adapter, and it subtracts from every dissociation measured afterwards.

Practical notes

See also: immobilization method comparison table.